Validating TDP1 as an Inhibition Target for the Development of Chemosensitizers for Camptothecin-Based Chemotherapy Drugs
Euphemia Leung(Cancer Society of New Zealand), Ivanhoe K. H. Leung(University of Auckland)
Cited by 20
Related Papers
Anti-apoptotic proteins in the autophagic world: an update on functions of XIAP, Survivin, and BRUCE
|Journal of Biomedical Science|2020|98
Evidence for the Existence of Triple-Negative Variants in the MCF-7 Breast Cancer Cell Population
|BioMed Research International|2014|46
Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines
|PLoS ONE|2015|45
Evidence that phospholipase C is involved in the antitumour action of NSC768313, a new thieno[2,3-b]pyridine derivative
|Cancer Cell International|2016|35